Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9609-9613

  Nardelli Haefliger, Denise ^a,c   Roden, Richard ^b   Balmelli, Carole ^a   Potts, Alexandra ^a   Schiller, John ^b   De Grandi, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c c/o Institut de Microbiologic ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRUS CYCLE; FEMALE; IMMUNOPROPHYLAXIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS PARTICLE; WART VIRUS;

EID: 0032826809     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9609-9613.1999     Document Type: Article

References (47)

1. Allen, E. 1922. The oestrous cycle in the mouse. Am. J. Anat. 30:290-371.
2. Balmelli, C., R. Roden, A. Potts, J. Schiller, P. De Grandi, and D. Nardelli-Haefliger. 1998. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J. Virol. 72:8220-8229.
3. Bergquist, C., E.-L. Johansson, T. Lagergård, J. Holmgren, and A. Rudin. 1997. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65:2676-2684.
4. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87:796-802.
5. Bouvet, J.-P., L. Bélec, R. Pirès, and J. Pillot. 1994. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect Immun. 62:3957-3961.
6. Brandtzaeg, P. 1997. Mucosal immunity in the female genital tract. J. Reprod. Immunol. 36:23-50.
7. Breilburd, F., R. Kirnabauer, N. L. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J, Virol. 69:3959-3963.
8. Chong, C., M. Friberg, and J. D. Clements. 1998. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine 16:732-740.
9. Czerkinsky, C. C., L. A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarfcowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
10. deHaan, A., K. B. Renegar, P. J. Small, and J. Wilschut. 1995. Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen. Vaccine 13:613-616.
11. De Magistris, M., M. Pizza, G. Douce, P. Ghiara, G. Dougan, and R. Rappuoli. 1998. Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunization. Dev. Biol. Stand. 92:123-126.
12. Di Tommaso, A., G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G. Douce, and M. De Magistris. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:974-979.
13. Gallicban, W. S., and K. L. Rosenthal. 1996. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 224:487-497.
14. Gallichan, W. S., and K. L. Rosenthal. 1995. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13:1589-1595.
15. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:315-322.
16. Hofmann, K. J., J. C. Cook, J. G. Joyce, D. R. Brown, L. D. Schultz, H. A. George, M. Rosolowsky, K. H. Fife, and K. U. Jansen. 1995. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 209:506-518.
17. Hopkins, S., J.-P. Kraehenbuhl, F. Schodel, A. Potts, D. Peterson, P. De Grandi, and D. Nardelli-Haefliger. 1995. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63:3279-3286.
18. Kirnbauer, R, F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
19. Kirnbauer, R., L. M. Chandrachud, B. W. Oneil, E. R. Wagner, G. J. Grindlay, A. Armstrong, G. M. McGarvie, J. T. Schiller, D. R. Lowy, and M. S. Campo. 1996. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology 219:37-44.
20. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Dürst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
21. Kraehenbühl, J.-P., and M. R. Neutra. 1992. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol. Rev. 72:853-879.
22. Kutteh, VV. H., S. J. Prince, K. R. Hammond, C. C. Kutteh, and J. Mestecky. 1996. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 104: 538-542.
23. Lowe, R. S, D. R. Brown, J. T. Bryan, J. C. Cook, H. A. George, K. J. Hofmann, W. M. Hurni, J. G. Joyce, E. D. Lehman, H. Z. Markus, M. P. Neeper, L. D. Schultz, A. R. Shaw, and K. U. Jansen. 1997. Human papillomavirus type ii (hpv-11) neutralizing antibodies in the serum and genital mucosal secretions of african green monkeys immunized with hpv-11 virus-like particles expressed in yeast. J. Infect. Dis. 176:1141-1145.
24. Lowy, D. R., R. Kirnbauer, and J. T. Schiller. 1994. Genital human papillomavirus infection. Proc. Natl. Acad. Sci. USA 91:2436-2440.
25. Mestecky, J., W. H. Kutteh, and S. Jackson. 1994. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res. Hum. Retroviruses 10:s11-s20.
26. Nardelli-Haefliger, D., R. B. S. Roden, J. Benyacoub, R. Sahli, J.-P. Kraehenbuhl, J. T. Schiller, P. Lachat, A. Potts, and P. De Grandi. 1997. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 65:3328-3336.
27. Ogra, P. L., and S. S. Ogra. 1973. Local antibody response to polio vaccine in the human female genital tract. J. Immunol. 110:1307-1311.
28. Pal, S., E. M. Peterson, and L. M. de la Maza. 1996. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect. Immun. 64:5341-5348.
29. Parr, E. L., and M. B. Parr. 1990. A comparison of antibody titers in mouse uterine fluid after immunization by several routes, and the effect of the uterus on antibody titers in vaginal fluid. J. Reprod. Fertil. 89:619-625.
30. Parr, M., and E. L. Parr. 1994. Mucosal immunity in the female and male reproductive tracts, p. 677-689. In P. L. Ogra et al. (ed.), Handbook of mucosal immunology. Academic Press, San Diego, Calif.
31. Parr, M. B., and E. L. Parr. 1985. Immunohistochemical localization of immunoglobulins A, G and M in the mouse female genital tract. J. Reprod. Fertil. 74:361-370.
32. Rachman, R., V. Casimiri, A. Psychoyos, and O. Bernard. 1983. Immunoglobulins in the mouse uterus during the estrous cycle. J. Reprod. Fertil. 69:17-21.
33. Roden, R. B. S., H. L. Greenstone, R. Kirnbauer, F. P. Booy. J. Jessie, D. R. Lowy, and J. T. Schiller. 1996. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70: 5875-5883.
34. Rose, R. C., R. C. Reichmann, and W. Bonnez. 1994. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. J. Gen. Virol. 75:2075-2079.
35. Russell, M. W., Z. Moldoveanu, P. L. White, G. J. Sibert, J. Mestecky, and S. M. Michalek. 1996. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect. Immun. 64:1272-1283.
36. Sasagawa, T., P. Pushko, G. Steers, S. E. Gshmeissner, M. A. N. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.
37. Schumacher, G. F. B. 1980. Humoral immune factors in the female reproductive tract and their changes during the cycle. Elsevier/North Holland, New York, N. Y.
38. Sedgwick, J. D., and P. G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301-309.
39. Staats, H. F., W. G. Nichols, and T. J. Palker. 1996. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:462-472.
40. Sullivan, D. A., G. S. Richardson, D. T. MacLaughlin, and C. R. Wira. 1984. Variations in the levels of secretory component in human uterine fluid during the menstrual cycle. J. Steroid Biochem. 20:509-513.
41. Suzich, J. A., S. J. Ghim, F. J. Palmerhill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus 11 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
42. Tauber, P. F., G. M. Cramer, and L. J. Zaneveld. 1993. Effect of the intrauterine contraceptive device on protein components of human uterine fluid. Contraception 48:494-512.
43. Thapar, M. A., E. L. Parr, and M. B. Parr. 1990. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 70:121-125.
44. Underdown, B. J., and J. Mestecky. 1994. Mucosal immunoglobulins. Academic Press, San Diego, Calif.
45. Usala, S. J., F. O. Usala, R. Haciski, J. A. Holt, and G. F. Schumacher. 1989. IgG and IgA content of vaginal fluid during the menstrual cycle. J. Reprod. Med. 34:292-294.
46. Wira, C., J. Richardson, and R. Pabhala. 1994. Endocrine regulation of mucosal immunity: effect of sex hormones and cytokine on the afferent and efferent arms of the immune system in the female reproductive tract, p. 707-718. In P. L. Ogra et al. (ed.), Handbook of mucosal immunology. Academic Press, San Diego, Calif.
47. Wira, C. R., and C. Kaushic. 1996. Mucosal immunity in the female reproductive tract: effect of sex hormones on immune recognition and responses, p. 375-388. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, San Diego, Calif.